Study of the Effects of Pomegranate Tablets on Enlarged Prostates

• Status: Unknown status
• Trial end date: 2010-06-01
• Target enrollment: 0
• Participant gender: Male

Summary

To determine whether pomegranate tablets have a therapeutic effect on Benign Prostatic Hyperplasia.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, Irvine
• Collaborators: Jarrow Pharmaceuticals; Pomegranate Health

Criteria

Inclusion Criteria:

• 18 years of age or older

• Clinically diagnosed with mild to moderate BPH (AUA symptom score <20)

Exclusion Criteria:

• Patient with severe BPH (AUA symptom score >21)

• Currently using any other forms of medical therapy, prescription finasteride, terazosin, tamsulosin or propecia (for hair loss).

• Prior Transurethral resection of the prostate (TURP).

• Using non-prescription supplements such as Saw Palmetto, B-sitosterol, vitamin E, and quercetin.